Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/28380
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-08-26T06:20:19Z | - |
dc.date.available | 2022-08-26T06:20:19Z | - |
dc.date.issued | 2014-12 | - |
dc.identifier.citation | Şentürk, T. vd. (2014). "Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury". Atherosclerosis, 237(2), 760-766. | en_US |
dc.identifier.issn | 0021-9150 | - |
dc.identifier.issn | 1879-1484 | - |
dc.identifier.uri | https://doi.org/10.1016/j.atherosclerosis.2014.10.091 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0021915014015469 | - |
dc.identifier.uri | http://hdl.handle.net/11452/28380 | - |
dc.description.abstract | Objective: Apoptosis is the early and predominant form of cell death in infarcted myocardia. The aim of the study was to investigate the effects of trimetazidine (TMZ) and N-acetylcysteine (NAC), used alone or in combination, on oxidative stress, infarct size, and ischemia-reperfusion (IR)-induced cardiomyocyte apoptosis in a rat model of myocardial IR. Methods and results: Myocardial IR was established by ligating an area under the left main coronary artery for 30 min followed by 3 h of reperfusion. Saline (1 ml/kg), NAC (50, 150 mg/kg), or TMZ (3, 5 mg/kg) was intravenously injected during the middle of the ischemic period. At the end of the reperfusion, blood samples were collected from the animals to measure serum M30 and M65 levels, which are markers of cell death, the S100b level, which is a marker of inflammation, and the malondialdehyde (MDA) level, which is a marker of oxidative stress. The infarct size was evaluated as the ratio of the infarct area to the risk area. Apoptotic activation was assessed by caspase-3 immunostaining and a TUNEL assay. TMZ and NAC, either alone or in combination, significantly reduced serum MDA levels, infarct area and apoptotic activity compared to those observed in saline group. Interestingly, the infarct area was more smaller in TMZ (3 and 5 mg/kg) injected groups (9.72 +/- 1.3% and 9.96 +/- 2.3%) than those observed in NAC (50 and 150 mg/kg) (16.1 +/- 2.5% and 19.1 +/- 2.14%) or TMZ (5 mg/kg)- NAC (150 mg/kg) combination groups (16.9 +/- 1.6%). However, the apoptotic activity was reduced more significantly in the combination of TMZ (5 mg/kg)-NAC (50 mg/kg) compared to TMZ-only group. Neither TMZ or NAC treatments nor the combination of the drugs significantly affected serum M30, M65 and S100B levels. Conclusion: Intravenous NAC and TMZ administration decreased oxidative stress, infarct area and apoptotic activity in a rat model of IR. Although the combination treatment was more effective in reducing the apoptotic activity than either treatment groups alone, TMZ treatment was more successful in reducing the infarct area than NAC or combination treatments. Present results suggest that, in addition to mechanical attempts to secure myocardial reperfusion, the use of TMZ and NAC may help to reduce IR injury. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Trimetazidine | en_US |
dc.subject | N-acetylcysteine | en_US |
dc.subject | Myocardium | en_US |
dc.subject | Reperfusion injury | en_US |
dc.subject | Apoptosis | en_US |
dc.subject | Oxidative stress | en_US |
dc.subject | M30/M65 | en_US |
dc.subject | Free-fatty-acids | en_US |
dc.subject | Infarct size | en_US |
dc.subject | Endothelial-cells | en_US |
dc.subject | Heart | en_US |
dc.subject | Nitroglycerin | en_US |
dc.subject | Arrhythmias | en_US |
dc.subject | Activation | en_US |
dc.subject | Severtiy | en_US |
dc.subject | Disease | en_US |
dc.subject | Glucose | en_US |
dc.subject | Cardiovascular system & cardiology | en_US |
dc.title | Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000346066600086 | tr_TR |
dc.identifier.scopus | 2-s2.0-84910630607 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Farmakoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Histoloji ve Embriyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyokimya Anabilim Dalı. | tr_TR |
dc.relation.bap | UAP(T)-2009/6 | tr_TR |
dc.identifier.startpage | 760 | tr_TR |
dc.identifier.endpage | 766 | tr_TR |
dc.identifier.volume | 237 | tr_TR |
dc.identifier.issue | 2 | tr_TR |
dc.relation.journal | Atherosclerosis | en_US |
dc.contributor.buuauthor | Şentürk, Tunay | - |
dc.contributor.buuauthor | Çavun, Sinan | - |
dc.contributor.buuauthor | Avcı, Berrin | - |
dc.contributor.buuauthor | Yermezler, Aysun | - |
dc.contributor.buuauthor | Serdar, Zehra | - |
dc.contributor.buuauthor | Savcı, Vahide | - |
dc.contributor.researcherid | ABE-6685-2020 | tr_TR |
dc.contributor.researcherid | AAC-9702-2019 | tr_TR |
dc.contributor.researcherid | C-1517-2017 | tr_TR |
dc.identifier.pubmed | 25463117 | tr_TR |
dc.subject.wos | Cardiac & cardiovascular systems | en_US |
dc.subject.wos | Peripheral vascular disease | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q1 | en_US |
dc.contributor.scopusid | 8342098300 | tr_TR |
dc.contributor.scopusid | 6507468595 | tr_TR |
dc.contributor.scopusid | 6603017388 | tr_TR |
dc.contributor.scopusid | 55938747300 | tr_TR |
dc.contributor.scopusid | 57222002284 | tr_TR |
dc.contributor.scopusid | 6603687024 | tr_TR |
dc.subject.scopus | Trimetazidine; Heart Failure; Ketone Bodies | en_US |
dc.subject.emtree | Acetylcysteine | en_US |
dc.subject.emtree | Biological marker | en_US |
dc.subject.emtree | Caspase 3 | en_US |
dc.subject.emtree | Cytokeratin 18 | en_US |
dc.subject.emtree | m65 protein | en_US |
dc.subject.emtree | Malonaldehyde | en_US |
dc.subject.emtree | Protein S100B | en_US |
dc.subject.emtree | Sodium chloride | en_US |
dc.subject.emtree | Trimetazidine | en_US |
dc.subject.emtree | Unclassified drug | en_US |
dc.subject.emtree | Animal cell | en_US |
dc.subject.emtree | Animal experiment | en_US |
dc.subject.emtree | Animal model | en_US |
dc.subject.emtree | Animal tissue | en_US |
dc.subject.emtree | Apoptosis | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Coronary artery ligation | en_US |
dc.subject.emtree | Coronary risk | en_US |
dc.subject.emtree | Experimental myocardial ischemia | en_US |
dc.subject.emtree | Heart infarction prevention | en_US |
dc.subject.emtree | Heart infarction size | en_US |
dc.subject.emtree | Heart muscle cell | en_US |
dc.subject.emtree | Heart muscle reperfusion | en_US |
dc.subject.emtree | Immunohistochemistry | en_US |
dc.subject.emtree | Inflammation | en_US |
dc.subject.emtree | Left coronary artery | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Monotherapy | en_US |
dc.subject.emtree | Nick end labeling | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Oxidative stress | en_US |
dc.subject.emtree | Rat | en_US |
dc.subject.emtree | Reperfusion injury | en_US |
dc.subject.emtree | Serum | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.